Insider buying last 90 days
No open-market insider purchases were filed for ACMR in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
ACM Research posted Q3 2026 results this week, with revenue up 36.6% year-over-year to $367.7 million and non-GAAP diluted EPS of $0.55, both ahead of estimates, while GAAP net income fell to $1.544 million from $35.889 million on a $39.133 million unrealized loss. ECP and advanced packaging demand drove the growth, and the company raised its 2026 revenue outlook, citing a record $2.5 billion backlog and stronger equipment orders. Analyst commentary following the report framed the pullback in shares as a possible risk-to-reward setup given the liquidity position of $1.32 billion against $148 million in debt, even as sector-wide sentiment stayed negative.
Shares closed at $49.75, down from recent highs and sitting below both the 50-day average of $64.42 and the 200-day average of $68.37, with the 50-day also below the 200-day. The stock's one-month return stands at -30.3% and its three-month return at -37.8%, against a 52-week range of $28.46 to $127.19. The GekkoIndex reads 65.6, placing ACMR in the Accumulation zone, down 6.4 points over five days. Gekko Fair Value is $75.39, putting the current price 34% below that level.
The next earnings date is 25 February 2027, 102 days away, outside a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows, though one billionaire holder and three trailblazer holders are noted. Seasonality over the next 20 trading days has averaged -6.3% across 5 years, rising in 3 of them. Three analyst firms currently rate the stock buy, with a consensus target of $115.33.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
ACM Research scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed2 headwinds
Below 50 and 200-day
Close $47.95 is below the 50-day ($62.76) and 200-day ($68.29) averages, and the 50-day is below the 200-day.
See the chart61.9, Accumulation
Reading 61.9 is in the Accumulation zone.
See the GekkoIndex32.9% below
Price is 32.9% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 102 days
Next report Feb 25, 2027, 102 days away — outside a typical 20-trading-day hold.
See earnings−4.4% on average
From this point in the calendar, the next 20 trading days averaged −4.4% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
ACM Research closed at $47.95 on Nov 13, 2026, +41.8% over the past year, inside a 52-week range of $28.46 to $127.19.
Use the left and right arrow keys to read daily values.
Put ACMR on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
ACM Research designs, builds and supplies specialized single-wafer wet cleaning systems used in semiconductor manufacturing. These machines are built to help chipmakers improve production quality and boost the output of usable integrated circuits. The company is known for a set of proprietary cleaning technologies, including systems that apply megasonic energy evenly across wafer surfaces, methods tailored for cleaning complex patterned wafers at advanced process stages, an approach that cuts back on the chemicals used in cleaning, and equipment for electro-chemical metal plating.
ACM Research sells its equipment under the Ultra C product name, reaching customers through its own sales team as well as independent outside representatives who distribute on its behalf.
The company traces back to 1998 and operates out of Fremont, California. Its shares trade on the NASDAQ under the ticker ACMR.
ACM Research’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 61.9, in the Accumulation zone, down 9 points over five sessions.
Down 9 points over five sessions, from the Buying zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 42 | +3.3% | +29.2% | ||
| Accumulation (current zone) | 233 | −0.3% | +4.8% | ||
| Neutral | 347 | +1.3% | +3.2% | ||
| Distribution | 72 | +4.0% | +11.4% | ||
| Selling | 8 | Too few readings yet | |||
Average ACMR share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
ACM Research trades 32.9% below Gekko Fair Value of $71.49, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what ACM Research shares are worth, recalculated every trading day.
$71.49
Gekko Fair Value, Nov 14, 2026
32.9% Undervalued
At the end of Aug 2026 the price was 32.2% below the estimate.
No open-market insider purchases were filed for ACM Research, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for ACMR in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in ACMR were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
ACM Research has been buying back its own shares.
From company filings.
4of the funds Gekko tracks hold ACMR.
ACM Research reports on Feb 25, 2027, before the open (102 days away), and beat the EPS estimate in 6 of its last 8 reports.
Feb 25, 2027
Expected before the open, 102 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 7, 2026 | $0.61 est $0.42 | $292.9M est $269.3M | +0.5% |
| May 7, 2026 | $0.34 est $0.20 | $231.3M est $215.7M | +8.1% |
| Feb 26, 2026 | $0.25 est $0.53 | $244.4M est $241.3M | −18.7% |
| Nov 5, 2025 | $0.36 est $0.47 | $269.2M est $248.4M | −20.5% |
| Aug 6, 2025 | $0.54 est $0.42 | $215.4M est $252.2M | −18.1% |
| May 8, 2025 | $0.46 est $0.37 | $172.3M est $221.0M | +10.8% |
| Feb 26, 2025 | $0.56 est $0.31 | $223.5M est $179.7M | +13.8% |
| Nov 7, 2024 | $0.63 est $0.37 | $204.0M est $191.2M | +1.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for ACM Research is $103.56, +116.0% from the last close, from 3 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 3 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 9 | Goldman Sachs | $140 | +192.0% |
| Nov 5 | Roth MKM | $60 | +25.1% |
| Oct 5 | Goldman Sachs | $159 | +231.6% |
| Aug 25 | Daiwa | $136 | +183.6% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, ACM Research averaged −4.4% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −5.0% | 1 of 5 |
| Next 10 trading days | −6.9% | 1 of 5 |
| Next 15 trading days | −10.4% | 1 of 5 |
| Next 20 trading days | −4.4% | 2 of 5 |
| Next 30 trading days | −5.4% | 2 of 5 |
For scale, ACMR’s typical 20-trading-day move in either direction is about 15.3%.
ACM Research’s market cap is $3.10B, with a P/E ratio of 29.8 and revenue of $1.14B over the last twelve months.
Coverage of ACM Research this week reads negative: 0 positive, 1 neutral and 2 negative headlines.
ACM Research’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| AMATApplied Materials | Accumulation | 27.3% below |
| LRCXLam Research | Accumulation | 14.7% below |
| PHParker-Hannifin | Neutral | 4.5% above |
| TTTrane Technologies | Accumulation | 6.8% above |
| JCIJohnson Controls International | Accumulation | 6.6% above |
| CARRCarrier Global | Neutral | 0.0% above |
A peer links to its own page where one exists.
ACM Research’s market cap is $3.10B at the Nov 13, 2026 close of $47.95, with 65.02M shares outstanding. The shares trade on a P/E ratio of 29.8.
The consensus analyst 12-month price target for ACM Research is $103.56, +116.0% from the last close. Of the 3 firms that rated the stock in the last 90 days, 3 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate ACM Research is undervalued: the Nov 13, 2026 close of $47.95 is 32.9% below Gekko Fair Value of $71.49. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
ACM Research is expected to report on Feb 25, 2027, before the market opens (102 days away). Analysts expect earnings of $0.64 per share on revenue of $367.3M. ACM Research beat the earnings estimate in 6 of its last 8 reports, moving 11.5% on average across the report.
ACM Research’s 52-week high is $127.19 and its 52-week low is $28.46; it closed at $47.95 on Nov 13, 2026, +41.8% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk) and 2 as headwinds (trend and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.